Sanjana Suraneni

Sanjana Suraneni

Auto-generated profile, based on publicly available information

Sanjana Suraneni

From the Bascom Palmer Eye Institute (S.S., A.M.A., S.L., R.S.T.), University of Miami, Miami, Florida, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2024 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
AAAbdelrahman M. Anter
Abdelrahman M. Anter
ABAdam R. Bleeker
Adam R. Bleeker
HSH. John Shammas
H. John Shammas
SSSanjana Suraneni
Sanjana Suraneni
BKBrandon Kingrey
Brandon Kingrey
Kamran RiazKamran Riaz
Kamran Riaz

1 October 2024 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Open access
HSH. John Shammas
H. John Shammas
DCDavid L. Cooke
David L. Cooke
Kamran RiazKamran Riaz
Kamran Riaz
RTRahul Md Tonk
Rahul Md Tonk
MSMaya C. Shammas
Maya C. Shammas
SLSebastian Bs Leal
Sebastian Bs Leal
Purpose: To describe the Shammas-Cooke formula, an updated no-history (NH) formula for IOL calculation in eyes with prior myopic laser vision correction (M-LVC), and to compare the results with the Shammas PL, Haigis-L, and Barrett True-K NH formulas. Setting: Bascom Palmer Eye Institute (BPEI), The Lennar Foundation Medical Center, University of Miami, Miami, Florida; Dean A. McGee Eye Institute (DMEI), University of Oklahoma, Oklahoma City, Oklahoma; and private practice, Lynwood, California, and St Joseph, Michigan. Design: Retrospective observational study. Methods: We analyzed 2 large series of cataractous eyes with prior M-LVC. The training set (BPEI series of 330 eyes) was used to derive the new corneal power conversion equation to be used in the new Shammas-Cooke formula and the testing set (165 eyes of 165 patients in the DMEI series) to compare the updated formula with 3 other M-LVC NH formulas on the ASCRS calculator: Shammas PL, Haigis-L, and Barrett True-K NH. Results: Mean prediction error was 0.09 ± 0.56 diopters (D), −0.44 ± 0.61 D, −0.47 ± 0.59 D, and −0.18 ± 0.56 D and the mean absolute error was 0.43 D, 0.60 D, 0.61 D, and 0.45 D for the Shammas-Cooke, Shammas PL, Haigis-L, and Barrett True-K NH, respectively. The percentage of eyes within ±0.50 D was 66.7% vs 47.9%, 48.5%, and 65.5%, respectively. Conclusions: The Shammas-Cooke formula performed better than the Shammas PL and Haigis-L (P < .001 for both) and as well as the Barrett True-K NH formula (P = .923).

9 September 2025 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
SSSanjana Suraneni
Sanjana Suraneni
ABAdam R. Bleeker
Adam R. Bleeker
AAAbdelrahman M. Anter
Abdelrahman M. Anter
SLSebastian Leal
Sebastian Leal
DMDavid A. Murphy
David A. Murphy
RTRahul S. Tonk
Rahul S. Tonk

24 October 2024 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
SSSanjana Suraneni
Sanjana Suraneni
CTCharissa Tan
Charissa Tan
LFLindsay M. Foley
Lindsay M. Foley
SDSander R. Dubovy
Sander R. Dubovy
BJBasil Williams Jr.
Basil Williams Jr.
AZAngela Y. Zhu
Angela Y. Zhu
Purpose: To report a case of corneoscleral juvenile xanthogranuloma (JXG) with progressive anterior segment involvement refractory to topical steroids. Observations: A 4-month-old male was referred for a new-onset subconjunctival lesion in the right eye. He was found to have a thickened, yellow corneoscleral lesion and hyphema, presumed to be ocular JXG. He was started on topical steroids as empiric treatment, with initial improvement for the first 3 months. Despite remaining on topical steroids, the lesion persisted and was biopsied at age 8 months. Conjunctival, scleral, and aqueous biopsies ruled out uveitic and malignant etiologies and were consistent with JXG with CD68-positive histiocytes, CD3-positive T cells, and CD20-positive B cells. Over the next few months, axial length increased out of proportion to normal growth, and intraocular pressure was elevated despite multiple pressure-lowering drops. At age 11 months, the patient acutely developed a flat anterior chamber with complete keratolenticular and iridocorneal adhesions secondary to a pupillary membrane. The patient improved after undergoing placement of an Ahmed drainage implant, synechiolysis, pars plana lensectomy and vitrectomy, subconjunctival and intravitreal injection of bevacizumab, and intravitreal methotrexate. Conclusions and importance This is a rare presentation of ocular JXG presenting with diffuse infiltration of the sclera, cornea, and iris. Given the involvement of multiple ocular structures, progression despite initial response to topical steroids, and increased intraocular pressure, aggressive management was required. Lesions should be closely monitored for progression and may benefit from surgical intervention and treatment with intraocular bevacizumab and/or methotrexate if topical steroids are insufficient.

19 February 2025 in Journal of Vitreoretinal Diseases
Verified
Journal Article
Closed access
AGAraliya N. Gunawardene
Araliya N. Gunawardene
SSSanjana Suraneni
Sanjana Suraneni
LRLandon Rohowetz
Landon Rohowetz
JSJayanth Sridhar
Jayanth Sridhar
Purpose: To assess the content and medical accuracy of retina-related patient discussions on Reddit, an anonymous social media platform, to better understand the main concerns and reliability of a highly accessible resource. Methods: A cross-sectional analysis was performed of the top 20 posts and top 3 comments from 2011 to 2022 on the Reddit subforums r/Optometry and r/EyeTriage containing the following keywords: “retinal detachment”, “macular edema”, “macular degeneration”, and “diabetic retinopathy”. Results: This study assessed 407 posts and comments. Most users who posted were current patients (n = 71 [60.2%]). Most commenters did not specify their identity (n = 172 [59.5%]). A portion of respondents identified as optometrists (n = 51 [17.6%]), and few identified as ophthalmologists (n = 11 [3.8%]). Many statements were medically inaccurate (n = 31 [40.8%]), with pathophysiology comprising the most commonly misunderstood topic (n = 15 [48.4%]). Conclusions: Given the prevalence of inaccurate information and the lack of credibility among Reddit posters, patients should take caution in using these sites for medical guidance regarding retinal conditions.